Effectiveness and safety of glecaprevir/pibrentasvir in chronic hepatitis C patients: Results of the Italian cohort of a post-marketing observational study

Alessio Aghemo, Alfredo Alberti, Alessia Alberti, Pietro Andreone, Mario Angelico, Maurizia Rossana Brunetto, Luchino Chessa, Alessia Ciancio, Antonio Craxì, Giovanni Battista Gaeta, Massimo Galli, Antonio Gasbarrini, Alessia Giorgini, Elisabetta Grilli, Pietro Lampertico, Miriam Lichtner, Michele Milella, Filomena Morisco, Marcello Persico, Mario PirisiMassimo Puoti, Giovanni Raimondo, Antonietta Romano, Maurizio Russello, Vincenzo Sangiovanni, Monica Schiavini, Gaetano Serviddio, Erica Villa, Maria Vinci, Maria Rosaria Vinci, Antonella De Michina, Valentina Gallinaro, Giuliana Gualberti, Antonio Saverio Roscini, Anna Linda Zignego

Risultato della ricerca: Contributo in rivistaArticolo in rivista

Fingerprint

Entra nei temi di ricerca di 'Effectiveness and safety of glecaprevir/pibrentasvir in chronic hepatitis C patients: Results of the Italian cohort of a post-marketing observational study'. Insieme formano una fingerprint unica.

Pharmacology, Toxicology and Pharmaceutical Science